AdaptHealth (NASDAQ:AHCO) Upgraded at Jefferies Financial Group

Jefferies Financial Group upgraded shares of AdaptHealth (NASDAQ:AHCO) from a hold rating to a buy rating in a research report report published on Tuesday morning, Marketbeat reports. The firm currently has $13.00 target price on the stock, up from their previous target price of $11.00.

Several other equities analysts have also weighed in on the stock. Truist Financial lifted their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Monday, April 13th. Royal Bank Of Canada increased their price target on shares of AdaptHealth from $13.00 to $15.00 and gave the stock an “outperform” rating in a report on Monday, May 11th. Wall Street Zen upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of AdaptHealth in a report on Friday, May 22nd. Finally, Canaccord Genuity Group upped their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Seven investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $14.14.

AdaptHealth Stock Down 3.8%

Shares of AHCO stock opened at $10.47 on Tuesday. The stock has a 50 day moving average of $10.24 and a 200 day moving average of $10.65. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. The stock has a market cap of $1.42 billion, a P/E ratio of -16.89, a P/E/G ratio of 0.55 and a beta of 1.45. AdaptHealth has a twelve month low of $8.51 and a twelve month high of $13.43.

Insider Buying and Selling at AdaptHealth

In other news, insider Russell E. Schuster III sold 11,275 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the transaction, the insider owned 136,538 shares in the company, valued at $1,373,572.28. This trade represents a 7.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by insiders.

Hedge Funds Weigh In On AdaptHealth

Large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in shares of AdaptHealth by 4.4% during the 4th quarter. Vanguard Group Inc. now owns 11,768,599 shares of the company’s stock worth $117,215,000 after purchasing an additional 491,106 shares during the last quarter. Deerfield Management Company L.P. boosted its stake in shares of AdaptHealth by 15.9% in the third quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock worth $102,726,000 after acquiring an additional 1,572,835 shares during the last quarter. Reinhart Partners LLC. increased its position in shares of AdaptHealth by 10.6% during the fourth quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock worth $80,684,000 after purchasing an additional 773,727 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of AdaptHealth by 8.1% during the first quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock worth $82,353,000 after purchasing an additional 518,274 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in AdaptHealth by 25.1% in the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock valued at $33,133,000 after purchasing an additional 558,357 shares during the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.